Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion type Assertion NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_head.
- NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion description "[Currently, targeted therapies (tamoxifen) are only able to reduce DCIS risk in patients with estrogen receptor ? (ER?)-positive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_provenance.
- NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion evidence source_evidence_literature NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_provenance.
- NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion SIO_000772 23752191 NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_provenance.
- NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion wasDerivedFrom befree-2016 NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_provenance.
- NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_assertion wasGeneratedBy ECO_0000203 NP1084704.RAWMQCamjR6mwrcBLdClZlKVXfdheROMhRS6oMEljaQwg130_provenance.